Specificity of retroviral proteinases based on substrates containing tyrosine and proline at the site of cleavage

  • József TÖzsÉr
Special Report
Received:
Accepted:

Abstract

The retroviral proteinase (PR) plays crucial roles in the viral life cycle, therefore it is a target for chemotherapy. However, resistance rapidly develops due to frequent mutations. Studies to determine the common features of the specificity of different retroviral PRs may help to design broad spectrum inhibitors and reduce the possibility of viable mutants. We have studied the specificity of various retroviral proteinases including those the PR of HIV-1, HIV-2, equine infectious anemia virus and avian myeloblastosis virus using oligopeptide substrates. A series of oligopeptides containing substitutions in a sequence Val-Ser-Gln-Asn-Tyr*Pro-Ile-Val-Gln (asterisk indicates the site of cleavage) representing a naturally occurring cleavage site in HIV-1 was used to characterize the seven substrate binding subsites of the enzymes. The unsubstituted substrate is a typical class 1 cleavage site substrate containing an aromatic amino acid and a proline residue at the site of cleavage. The largest differences in kinetics of substrate hydrolysis were obtained with peptides containing substitutions of the Ser and Asn residues. Detailed analysis of the results by molecular modeling and comparison with previously reported data revealed the common characteristics of the specificity of the PRs as well as its strong dependence on the sequence context of the substrate. However, molecular modeling in many cases provided explanation for the sequence context dependence. Also, comparison of the specificity of the enzymes suggests that the specificity of HIV-1 and -2 PRs is rather exceptional preferring hydrophilic residues at the most discriminative positions while other PRs prefer hydrophobic residues.

Key words

proteinases retroviral HIV cleavage specificity 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Kráusslich, HG, Oroszlan S andWimmer E: Viral proteinases as targets for chemotherapy. Curr Commun Mol Biol. Cold Spring Harbor Laboratory Press, New York. 1989.Google Scholar
  2. 2.
    Oroszlan S and Luftig RB: Retroviral proteinases. Curr Topics Microbiol Immunol 157:153–185, 1990.Google Scholar
  3. 3.
    Winslow DL and Otto MJ: HIV protease inhibitors. AIDS 9 (suppl A): S183-S192, 1995.PubMedGoogle Scholar
  4. 4.
    Mellors JW: Closing in on human immunodeficiency virus-1. Nat. Medicine 2:274–275, 1996.CrossRefGoogle Scholar
  5. 5.
    Oroszlan S, Henderson LE, Stephenson JR et al: Amino and carboxyl-terminal amino acid sequences of proteins coded by gag gene of murine leukemia virus. Proc Natl Acad Sci USA 75:1404–1408, 1978.PubMedCrossRefGoogle Scholar
  6. 6.
    Henderson LE, Benveniste RE, Sowder R et al: Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMnc). J Virol 62: 2587–2595, 1988.PubMedGoogle Scholar
  7. 7.
    Pettit SC, Simsic J, Loeb DD et al: Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the PI amino acid. J Biol Chem 266:14539–14567, 1991.PubMedGoogle Scholar
  8. 8.
    Griffith JT, Phylip LH, Konvalinka J et al: Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydropho-bic- or -aromatic*Pro- cleavage sites. Biochemistry 31:5193–5200, 1992.CrossRefGoogle Scholar
  9. 9.
    Tözsér J, Weber IT, Gustchina A et al: Kinetic and modeling studies of the S3-S3' subsites of HIV proteinase. Biochemistry 31:4793–4800, 1992.PubMedCrossRefGoogle Scholar
  10. 10.
    Schechter I and Berger A: On the size of the active site in proteases. I. papain. Biochem Biophys Res Commun 27:157–162, 1967.PubMedCrossRefGoogle Scholar
  11. 11.
    Tözsér J, Gustchina A, Weber IT et al: Studies on the role of the S4 binding site of HIV proteinases. FEBS Lett 279:356–360, 1991.PubMedCrossRefGoogle Scholar
  12. 12.
    Weber IT, Tözsér J, Wu J et al: Molecular model of equine infectious anemia virus proteinase and kinetic measurements for peptide substrates with single amino acid substitutions. Biochemistry 32:3354–3362, 1993.PubMedCrossRefGoogle Scholar
  13. 13.
    Tözsér J, Bagossi P, Weber IT et al: Comparative studies on the substrate specificity of avian myeloblastosis virus proteinase and lentiviral proteinases. J Biol Chem 271:6781–6788, 1996.PubMedCrossRefGoogle Scholar
  14. 14.
    Menéndez-Arias L, Weber IT, Soss J et al: Kinetic and modeling studies of subsites S4-S3 of Moloney murine leukemia virus protease. J Biol Chem 269:16795–16801, 1994.PubMedGoogle Scholar
  15. 15.
    Bagossi P, Cheng YSE, Oroszlan S and Tözsér J: Activity of linked HIV-1 proteinase dimers containing mutations in the active site region. Protein Eng 9:997–1003, 1996.PubMedCrossRefGoogle Scholar
  16. 16.
    Tözsér J, Yin FH, Cheng YSE et al: Activity of tethered human immunodeficiency virus 1 protease containing mutations in the flap region of one subunit. Eur J Biochem 244:235–241, 1997.PubMedCrossRefGoogle Scholar
  17. 17.
    Wlodawer A and Erickson JW: Structure-based inhibitors of HIV-1 protease. Ann Rev Biochem 62:543–585, 1993.PubMedCrossRefGoogle Scholar
  18. 18.
    Gustchina A, Kervinen J, Powell, DJ et al: Structure of equine infectious anemia virus proteinase complexed with an inhibitor. Protein Sci 5: 1453–1465, 1996.PubMedGoogle Scholar
  19. 19.
    Wlodawer A, Gustchina A, Reshetnikova L et al: Structure of an inhibitor complex of the proteinase from feline immunodeficiency virus. Nature Stuct Biol 2:480–488, 1995.CrossRefGoogle Scholar
  20. 20.
    Dunn BM, Gustchina A, Wlodawer A and Kay J: Subsite preferences of retroviral proteinases. Methods Enzymol 241, 254–278, 1994.PubMedCrossRefGoogle Scholar
  21. 21.
    Leis J, Baltimore D, Bishop JM et al: Standardized and simplified nomenclature for proteins common to all retroviruses. J Virol 62:1808–1809, 1988.PubMedGoogle Scholar

Copyright information

© W B. Saunders & Company Ltd 1997

Authors and Affiliations

  • József TÖzsÉr
    • 1
  1. 1.Department of BiochemistryUniversity Medical School of DebrecenDebrecenHungary

Personalised recommendations